Core Medical has completed nearly 200 million yuan in Series C financing.

Recently, the brain medical technology platform Juxin Medical Technology Co., Ltd. completed nearly 200 million yuan in Series C financing. This round of financing was led by Zhongshan Biomedical Angel Fund under Zhongshan Venture Capital, with BioMedicine Fund under Yuecai Zhongyin, Yueke Finance, Jingtai Capital, and Jinhai Qiyin Fund as follow-up investors. Existing shareholder Zhuhai Gaoke Investment continued to invest. Xiqiao Capital served as the exclusive financial advisor for this round of financing.